Protagonist Therapeutics Director Sells 20,000 Shares Amid Strong Stock Performance
In a recent insider transaction, Protagonist Therapeutics director William D. Waddill exercised stock options and sold 20,000 shares of PTGX…
In a recent insider transaction, Protagonist Therapeutics director William D. Waddill exercised stock options and sold 20,000 shares of PTGX…